Mark Sabag, See "Remarks" below at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 144,260 shares at $13.03 ($1.9M) on 2020-02-13, disclosed to the SEC on 2020-02-18.
Open-market sale of $1.9M TEVA by See "Remarks" below. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.03 | 72,130 | $940K | 50.0% |
| 2 | $13.03 | 72,130 | $940K | 50.0% |
| Total | $13.03 avg | 144,260 | $1.9M | 100% |
| Filing → |
| TEVA | SELL | 2025-12-11 | $9.0M | — | Filing → |
| TEVA | SELL | 2025-05-12 | $12.2M | — | Filing → |
| TEVA | SELL | 2025-02-14 | $5.8M | — | Filing → |